Font Size:

ALERT HAN Messages

The Alabama Department of Public Health (ADPH) has created the Alabama Emergency Response Technology (ALERT) to push health alert network (HAN) messages via email to healthcare providers statewide. ALERT HAN and FDA messages are intended to keep healthcare providers updated on new or emerging healthcare-related situations. ADPH will also send out the Centers for Disease Control and Prevention (CDC) HAN messages using ALERT.

If traveling out of the country, review CDC Travel Health Notices.

Table of Contents

View ADPH HAN Alert and CDC HAN Alert Archives

ADPH ALERT Messages

09/28/22
ADPH Health Advisory-Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID 19) Pandemic

09/28/22
Testing for Monkeypox (MPX) in Jefferson County

09/12/22
Joint Effort of ADPH and AMA to Stop the Rise of Congenital Syphilis in Alabama

08/31/22
Monkeypox Update

08/15/22
Bebtelovimab Commercial Transition

08/09/22
Highest Recorded Congenital Syphilis in Alabama: Let's Stop It!

08/02/22
Monkeypox Situation Update

07/18/22
Testing for Monkeypox (MPX) in Jefferson County

07/08/22
Guidance for Monkeypox Test Submission

07/05/22
Precautions for COVID-19 Therapeutics

06/18/22
CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries – 2022

05/26/22
UPDATED with additional Epidemiologic, Clinical, and Exclusion Criteria: CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries - 2022

05/24/22
COVID-19 Rebound after Paxlovid Treatment

05/23/22
CDC and ADPH Health Advisory on Monkeypox Virus Infections in the United States and Other Non-endemic Countries - 2022

05/06/22
Temporary Shortage of Contrast Media

05/02/22
Modifications to Reporting Requirements for Negative SARS-CoV-2 Antigen Results

04/28/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID -19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology Summary

04/07/22
Distribution of Sotrovimab Paused to All HHS Regions

03/17/22
Free CME Training Available-University of Alabama at Birmingham (UAB) Sanitation Health Study

02/14/22
Centers for Disease Control and Prevention (CDC) Updates COVID-19 Vaccination
Guidance

02/14/22
United States Food and Drug Administration (FDA) authorizes Eli Lilly’s COVID-19
Monoclonal Antibody Drug Bebtelovimab

02/01/22
Call to Report: Providers Encouraged to Report Certain Symptomatic Patients with
Adenovirus Infections

01/25/22
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to Omicron Variant

01/10/2022
Limited Therapeutic Options for Outpatient Treatment of COVID-19

01/07/2022
FDA Amends EUA for COMIRNATY/Pfizer-BioNTech and Moderna mRNA Vaccines and CDC/ACIP Endorses New Recommendations

01/03/2022
Monoclonal Antibody Update: Paused Monoclonal Antibodies for Treatment of COVID-19 Disease Available Again

 

CDC HAN Messages

06/14/22
Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022

05/24/22
COVID-19 Rebound after Paxlovid Treatment

05/20/22
Monkeypox Virus Infection in the United States and Other Non-endemic Countries --- 2022

05/11/22
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

04/25/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology





Page last updated: September 28, 2022